Owned organisations, commercial relationships and how they are kept separate from clinical decisions
A transparent ledger of every clinic, company, lab, technology platform and charity Professor Lee has founded, directs or holds a commercial interest in, and the policy that keeps clinical suitability decisions separate from commercial framing.
Why this page exists
Professor Paul Lee has built a body of clinical, academic, research and innovation work that spans more than one organisation. Several of those organisations were founded by him, are directed by him, or have a commercial relationship with him.
That makes this site, and the wider ecosystem of partner sites, more complex than a single hospital website. This page exists so that complexity is transparent, so that visitors, peers, regulators, solicitors, journalists and clinical colleagues can see at a glance what is owned, what is independent, and how the two are kept separate when clinical decisions are made.
Clinical services Professor Lee founded or directs
Clinics and clinical platforms where Professor Lee carries out private practice or holds an active founding-director role.
London Cartilage Clinic
Founder and Founding Medical Director; ICRS Accredited Teaching Centre of Excellence host site.
Specialist Harley Street clinic for cartilage injury, joint preservation and regenerative joint surgery.
VisitMSK Doctors
Founder and Founding Medical Director (since 2018).
Broader MSK clinical platform with the only dedicated musculoskeletal open MRI scanner in Lincolnshire.
VisitAMSK
Arthrosamid joint injections for patients, available nationwide, delivered to one trained clinical standard.
VisitThe Keep Clinic
Clinical brand under Professor Lee’s ownership operating as a distinct clinical service.
VisitLincolnshire Hip Clinic
Local clinical service for hip treatments in Lincolnshire.
VisitLincolnshire Knee Clinic
Local clinical service for knee treatments in Lincolnshire.
Visit
Treatment and condition sites
Specialist patient-education sites for named treatments and conditions, part of the wider clinical operation Professor Lee owns.
Hip Replacement Lincolnshire
Hip replacement for Lincolnshire patients using the SPAIRE approach (Save Piriformis And Internus, Repair Externus), which preserves the deep hip rotators for faster recovery.
VisitSpairehips
Clinical site dedicated to SPAIRE hip replacement (Save Piriformis And Internus, Repair Externus): the posterior approach that keeps the deep rotators attached for faster real-world recovery.
VisitLiquid Cartilage
Technique pioneered by Prof Lee at London Cartilage Clinic.
The Liquid Cartilage Plus + ChondroFiller cartilage-repair technique, explained for patients — what it is, who it suits and how it works — from the team that pioneered it at London Cartilage Clinic.
VisitACL.Repair
Specialist site for ACL repair, STARR augmented repair, ligament preservation and return-to-sport pathways.
VisitMeniscus.Repair
Repairing and preserving a torn meniscus, including augmented repair — the options explained for patients, from London Cartilage Clinic.
Visit
Research labs and the charity
Research infrastructure and the registered charity for MSK regeneration.
Research MSK
Research, articles and the clinical evidence behind the treatments — written as research and kept separate from the treatment sites.
VisitMSK Computer Vision Lab
Founder and Director (since 2021).
Sleaford-based lab pioneering computer vision and AI in musculoskeletal health: markerless motion capture, deep learning, applied ML.
MFO Life Sciences Lab
Founder and Principal Investigator (since 2025).
Grantham-based lab exploring regenerative medicine and the interaction between physical energy modalities and human tissue repair.
MSK Regen Foundation (charity)
Founder and Trustee; Scientific Committee Chair.
Charity (Charity Registration Number 1211400) dedicated to public musculoskeletal health, research and education in MSK regeneration.
Owned by Prof Lee. The Scientific Committee Chair role is therefore not independent.
Visit
Technology platforms
AI, imaging, motion-analysis and digital-consent platforms.
MAI Motion®
Conceived, founded and led the development.
AI-powered motion capture platform delivering objective biomechanical biomarkers. UKCA / MHRA-registered medical platform; Innovate UK KTP; patent pending.
VisitonMRI™
Founder and Strategic Lead. Innovate UK KTP; patent pending.
AI-driven MRI analysis system converting subjective interpretation into reproducible quantitative biomarkers (cartilage/meniscus segmentation, T2 mapping, low-field MRI compatibility).
Consent Plus
Founder and Project Lead.
Digital innovation for surgical consent. Won The Health Foundation Innovation Award and was adopted nationally.
VisitregenOS
Technology platform / operating system underpinning RegenPhD and recovery work.
STARR
Single Treatment ACL Regenerative Repair: augmented ligament repair technique pioneered at London Cartilage Clinic.
STACi
Single-stage Tissue-engineered Autologous Cartilage Implantation: single-stage cartilage cell therapy pioneered at London Cartilage Clinic.
Recovery and optimisation projects
Non-procedure recovery and optimisation work, kept clearly separate from clinical orthopaedic care.
RegenPhD
Creator.
Recovery, optimisation and longevity education platform.
VisitRegen Pod
Recovery, performance and longevity service. Not a substitute for clinical diagnosis, treatment, surgery, rehabilitation or medical care.
VisitregenEMS device
A recovery-focused electrical muscle stimulation (EMS) device used in RegenPhD's recovery programmes.
How clinical suitability is separated from commercial interest
Treatment selection for any individual patient is driven by the clinical picture (diagnosis, imaging, examination, comorbidities, function, goals) and not by where a given treatment is delivered or who supplies it. When Professor Lee considers a regenerative or named-procedure option for which he has a commercial interest, that interest is disclosed to the patient as part of the consent process, and an unbiased alternative pathway (including the option of further opinion) is offered as a matter of course.
Where the recommended treatment is provided by an entity Professor Lee does not own (an NHS pathway, another consultant, another provider) it is recommended on the same clinical merits and without preference for owned routes.
How to raise a concern
If you have a concern about a specific disclosure on this page, or about how a commercial interest has been managed in your individual clinical care, please get in touch via the work-with-Professor-Lee page. Patient-care complaints relating to clinical episodes are also handled through the formal complaints route of the clinic that provided your care.
Related governance pages
Credentials and independent verification
The independent counterpart to this page, what is NOT owned, with verification links.
Read
Editorial policy
How content is written, reviewed, sourced and corrected across the site.
Read
Projects and ecosystem
The full ecosystem map of clinical, research, technology, recovery and education entities.
Read